Skip to main content
. Author manuscript; available in PMC: 2015 Nov 23.
Published in final edited form as: Crit Pathw Cardiol. 2013 Jun;12(2):53–58. doi: 10.1097/HPC.0b013e318285ef60

Table 2.

Awareness, treatment and control of hypertension and diabetes

Hypertension Diabetes

n % 95%CI n % 95%CI
Overall*
Diagnosis awareness 99/205 48.3 40.8% – 55.9% 23/33 71.1 54.5% – 87.7%
Current treatment 34/99 40.0 29.5% – 50.5% 8/23 40.6 18.9% – 62.3%
Treated and controlled** 10/34 30.4 13.6% – 47.3% 1/8 7.7 --
Rural
Diagnosis awareness 12/33 36.4 20.4% – 54.9% 0/1 0 --
Current treatment 2/12 16.7 2.1% – 48.4% -- -- --
Treated and controlled 0/12 0 -- -- -- --
Migrant
Diagnosis awareness 59/106 55.7 45.7% – 65.3% 14/19 73.7 51.9% – 95.5%
Current treatment 18/59 30.5 19.2% – 43.9% 3/14 21.4 4.7% – 50.8%
Treated and controlled 6/18 33.3 13.3% – 59.0% 1/3 33.3 0.8% – 90.6%
Urban
Diagnosis awareness 28/66 42.4 30.3% – 55.2% 9/13 69.2 40.2% – 98.3%
Current treatment 14/28 50.0 30.6% – 69.4% 5/9 55.6 21.1% – 86.3%
Treated and controlled 4/14 28.6 8.4% – 58.1% 0/5 0.0 0
*

Overall prevalence and 95%CI were calculated using weights to account for participant’s group size, and this weighting was not applied in individual groups. 95%CI were not calculated when sample size was too small.

**

In the case of diabetes, all results treated and controlled figures shown were calculated using fasting glucose. For overall treated and controlled diabetes, if HbA1c <7.0% were to be used, then 0/8 patients would meet the criteria.